I get that you're only speculating. And I would maintain that to say '...such as kidney disease,..' would have also highlighted that this is a well known biosensor field that many are in and we could have then realised where AXE was attempting to bring a solution. I don't think it would have been spruiking. Somehow, and I'm of course speculating, this was what I think was the final straw.
I think I am more miffed that he demo-ed both 12CQ and bio chip to WEF. Would he have said the same there ? ' don't worry about what the chip will test for' ? Maybe he did. In which case, it amounts to nothing much in my book.
AXE Price at posting:
26.3¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)